Nicola A Hanania Selected Research

Immunoglobulin E (IgE)

1/2021	How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.
11/2020	Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.
1/2020	Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
1/2020	Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.
1/2018	Controversies and opportunities in severe asthma.
1/2017	Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
1/2016	Role of T2 inflammation biomarkers in severe asthma.
9/2014	Omalizumab in asthma: an update on recent developments.
1/2012	Targeting IgE in asthma.
4/2008	Targeting airway inflammation in asthma: current and future therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola A Hanania Research Topics

Disease

97	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 09/2003
85	Asthma (Bronchial Asthma) 10/2022 - 04/2004
27	Inflammation (Inflammations) 10/2022 - 03/2005
10	Dyspnea (Shortness of Breath) 01/2018 - 02/2007
6	Pneumonia (Pneumonitis) 11/2021 - 05/2013
5	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2020 - 03/2011
5	Emphysema 12/2017 - 06/2007
4	Hypersensitivity (Allergy) 01/2022 - 04/2008
4	COVID-19 11/2021 - 05/2020
4	Disease Progression 12/2019 - 01/2008
3	Hypoxia (Hypoxemia) 10/2022 - 08/2011
3	Airway Obstruction (Choking) 01/2022 - 10/2017
3	Infections 01/2021 - 01/2010
3	Chronic Disease (Chronic Diseases) 10/2020 - 01/2011
2	Lung Injury 05/2021 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Lung Diseases (Lung Disease) 01/2019 - 01/2017
2	Chronic Bronchitis 08/2016 - 01/2016
2	Eosinophilia 01/2016 - 01/2014
2	Fatigue 08/2012 - 03/2011
2	Respiratory Sounds (Crackle) 01/2011 - 12/2008
2	Respiratory Hypersensitivity 02/2009 - 01/2008
2	Human Influenza (Influenza) 02/2006 - 04/2004
1	Barotrauma 10/2022
1	Hypoventilation 10/2022
1	Hypercapnia 10/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Obesity 01/2022

Drug/Important Bio-Agent (IBA)

46	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 09/2003
30	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2011
29	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 09/2004
19	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 01/2006
12	GoldIBA 10/2020 - 03/2011
11	Omalizumab (Xolair)FDA Link 01/2022 - 04/2008
11	Biological ProductsIBA 01/2022 - 03/2011
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 04/2013
10	Immunoglobulin E (IgE)IBA 01/2021 - 04/2008
9	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 05/2005
9	Interleukin-13IBA 11/2020 - 09/2011
9	PeriostinIBA 01/2020 - 04/2013
7	SteroidsIBA 01/2022 - 04/2004
6	Oxygen (Dioxygen)IBA 03/2022 - 12/2005
6	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2014
6	dupilumabIBA 01/2022 - 01/2018
6	vilanterolIBA 01/2021 - 07/2012
6	lebrikizumabIBA 01/2018 - 09/2011
6	Tiotropium Bromide (Spiriva)FDA Link 01/2013 - 10/2007
6	Salmeterol Xinafoate (Serevent)FDA Link 01/2013 - 09/2003
5	Muscarinic AntagonistsIBA 10/2022 - 01/2015
5	Monoclonal AntibodiesIBA 01/2022 - 04/2008
5	fluticasone furoate FDA Link 01/2021 - 05/2013
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 01/2006
5	Pharmaceutical PreparationsIBA 01/2021 - 05/2011
5	AllergensIBA 11/2020 - 04/2008
5	Interleukin-5 (Interleukin 5)IBA 01/2019 - 05/2014
5	CytokinesIBA 01/2017 - 12/2009
5	Cholinergic Antagonists (Anticholinergics)IBA 01/2015 - 10/2007
4	InterleukinsIBA 11/2020 - 12/2009
4	SolutionsIBA 01/2019 - 02/2008
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 08/2018
3	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 01/2017
3	GSK573719IBA 01/2021 - 01/2021
3	SuspensionsIBA 04/2020 - 11/2016
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 09/2003
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
3	LeukotrienesIBA 01/2019 - 04/2008
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017 - 01/2010
3	tartaric acid (tartrate)FDA Link 12/2014 - 02/2007
3	AntigensIBA 01/2012 - 04/2004
3	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 02/2010 - 05/2005
3	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2006 - 04/2004
2	ProstaglandinsIBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2012
2	AerosolsIBA 01/2021 - 08/2017
2	Vitamin D FDA LinkGeneric 04/2013 - 01/2011
2	SmokeIBA 03/2012 - 10/2010
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2012 - 05/2005
2	Phenobarbital (Luminal)FDA Link 10/2010 - 06/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2010 - 05/2008
2	Levalbuterol (Xopenex)FDA LinkGeneric 01/2008 - 05/2006
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 12/2005 - 03/2005
1	MagnesiumIBA 10/2022
1	prostaglandin D2 receptorIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Famotidine (Pepcid)FDA LinkGeneric 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022

Therapy/Procedure

69	Therapeutics 10/2022 - 02/2002
14	Nebulizers and Vaporizers (Inhaler) 01/2021 - 09/2003
9	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 02/2007
6	Biological Therapy 01/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 10/2018 - 12/2007
4	Precision Medicine 01/2018 - 08/2016
3	Artificial Respiration (Mechanical Ventilation) 10/2022 - 05/2012
3	Length of Stay 03/2022 - 05/2012
3	Patient Readmission 01/2020 - 05/2015
3	Dry Powder Inhalers 01/2020 - 01/2018
2	Polypharmacy 11/2016 - 10/2010
2	Bronchial Thermoplasty 12/2013 - 07/2011
2	Pneumonectomy (Lung Volume Reduction) 01/2008 - 12/2005